???global.info.a_carregar???
Identification

Personal identification

Full name
Ana Catarina Alves

Author identifiers

Ciência ID
3E16-21FB-4B19
ORCID iD
0000-0003-3157-7542
Education
Degree Classification
2014/12/09 - 2014/12/11
Concluded
 GTPB Bioinformatics training course IB14S (Outros)
Major in Bioinformatics
Instituto Gulbenkian de Ciência, Portugal
2014
Concluded
 Química e Bioquimica (Doutoramento)
Universidade de Lisboa Faculdade de Ciências, Portugal
"Bases genética da Hipercolesterolemia Familiar" (THESIS/DISSERTATION)
 Distinção e Louvor
2012/05/23 - 2012/05/24
Concluded
 MicroRNA and cardiovascular diseases (Outros)
Major in genetics
European Atherosclerosis Society, Sweden
2003
Concluded
 Biotecnologia dos Produtos Naturais (Licenciatura)
Universidade Independente, Portugal
"Identificação de mutações no gene LDLR em doentes com Hipercolesterolemia Familiar" (THESIS/DISSERTATION)
 16
Affiliation

Science

Category
Host institution 		Employer
2021/03/01 - Current Auxiliary Researcher (Research) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Others

Category
Host institution 		Employer
2015/01/02 - Current Investigadora Auxiliar Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas, Portugal
2019/10/01 - 2020/12/31 Scientific Researcher FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2015 - 2019/09/30 Pos-Doc Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2014/11/05 - 2015/12/31 Pos-Doc Universidad del País Vasco - Campus Bizkaia, Spain
2012/02/01 - 2014/12/31 Field coordinator of the Project: e_COR (Prevalence of familial hypercholesterolemia and analysis of cardiovascular risk factors in the Portuguese population). Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2008/01/02 - 2014/11/04 phD student Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2004/01/02 - 2007/12/31 research fellowship in genetic of cardiovascular diseases Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2004/01 - 2007/12 research fellow Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2003/01/02 - 2003/12/15 trainee researcher in genetic of cardiovascular diseases Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Projects

Grant

Designation Funders
2014 - 2015 Prevalence of hepatic steatosis in Portugal
Prevalence of hepatic steatosis in Portugal
Other
Gilead Pharmaceutical
Concluded
2008 - 2010 "Coração Jovem
Fundação AstraZeneca
Other
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 AstraZeneca Produtos Farmacêuticos Lda
Concluded

Contract

Designation Funders
2018/10/01 - 2022/09/30 Estratificação da dislipidemia: Novas ferramentas de triagem para uma estratégia custo-efetiva
PTDC/SAU-SER/29180/2017
FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2018/09/03 - 2021/12/31 Biomoléculas para a Saúde: absorção de colesterol, e expressão das suas proteínas transportadoras, interacção com fármacos
PTDC/BIA-BQM/28355/2017
FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2020/02/04 - 2020/12/31 Novel mechanisms causing Familial Hypercholesterolaemia: Functional characterization of variants in the regulatory regions of PCSK9 and LDLR genes
UIDP/04046/2020
Principal investigator
Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas, Portugal
 Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas
Ongoing
2019 - 2020 Dyslipidaemia stratification: new screening tools for a cost effective approach
PTDC/SAU-SER/29180/2017
Researcher
Universidade de Lisboa Faculdade de Ciências, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2012 - 2017 Prevalence of familial hypercholesterolemia and analysis of cardiovascular risk factors in the Portuguese population
PIC/IC/83333/2007
Research Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2010 - 2017 Novel genes causing Familial Hypercholesterolaemia
FCT PTDC/SAU-GMG/101874/2008
Research Fellow
Fundação para a Ciência e a Tecnologia
2009/01/02 - 2013/01/01 Prevalência da hipercolesterolemia familiar e analise de factores de risco cardiovascular na população portuguesa
PIC/IC/83020/2007
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2009/01/02 - 2012/01/01 Estudo clinico e molecular de patologias familiares das lipoproteinas com elevado risco cardiovascular
PIC/IC/83333/2007
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2008/01/01 - 2011/12/31 GENETIC BASIS OF FAMILIAL HYPERCHOLESTEROLAEMIA
SFRH/BD/27990/2006
Universidade de Lisboa Faculdade de Ciências, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2010 - 2011 Clinical and molecular study of familial dyslipidaemia with increased cardiovascular risk
PIC/IC/83333/2007
Research Fellow
Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2016 - 2017 LAL _D.pt - Molecular study of LIPA gene in patients with unexplained severe dyslipidaemia,
LAL _D.pt
Post-doc Fellow
Alexion Pharmaceuticals Inc Lexington
Concluded
2016 - 2016 FH Genetic diagnosis Development and validation of support documentation for the molecular diagnosis of Familial Hypercholesterolaemia
FH Genetic diagnosis
Post-doc Fellow
Genediag.exe
Concluded
2014 - 2015 Assessment of the reduction of low-density lipoprotein cholesterol (LDL-C) by REGN1500 in patients with homozygous familial hypercholesterolemia
REGN1500
Post-doc Fellow
Regeneron Pharmaceuticals Inc
Concluded
Outputs

Publications

Conference poster
  1. Al-dewik, Nader Izz Eddin; Cassinat, Bruno; Kiladjian, Jean Jacques; Knuth, Alexander; Yassin, Mohamed A.. "Further evidence of novel APOB mutations as a cause of Familial Hypercholesterolaemia". Paper presented in european atherosclerosis society congress, 2015.
    10.5339/qfarc.2014.hbpp0336
Journal article
  1. Albuquerque, J.; Medeiros, A.M.; Alves, A.C.; Bourbon, M.; Antunes, M.. "Performance comparison of different classification algorithms applied to the diagnosis of familial hypercholesterolemia in paediatric subjects". Scientific Reports 12 1 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85123494118&partnerID=MN8TOARS.
    10.1038/s41598-022-05063-8
  2. Ferrinho, C.; Alves, A.C.; Bourbon, M.; Duarte, S.. "Applicability of Martin-Hopkins formula and comparison with Friedewald formula for estimated low-density lipoprotein cholesterol in e_COR study population,Aplicabilidade da fórmula Martin-Hopkins e comparação com a fórmula Friedewald na estimativa do colesterol LDL na população do estudo e_COR". Revista Portuguesa de Cardiologia 40 10 (2021): 715-724. http://www.scopus.com/inward/record.url?eid=2-s2.0-85111892990&partnerID=MN8TOARS.
    10.1016/j.repc.2020.11.011
  3. Ferreira, A.C.; Alves, A.C.; Medeiros, A.M.; Padeira, G.; Bourbon, M.. "Complex phenotype of hypercholesterolemia in a family with both ABCG8 and APOB mutations,Fenótipo complexo de hipercolesterolemia numa família com mutações ABCG8 e APOB". Portuguese Journal of Pediatrics 52 4 (2021): 317-322. http://www.scopus.com/inward/record.url?eid=2-s2.0-85121324627&partnerID=MN8TOARS.
    10.25754/pjp.2021.23815
  4. Vallejo-Vaz, A.J.; Stevens, C.A.T.; Lyons, A.R.M.; Dharmayat, K.I.; Freiberger, T.; Hovingh, G.K.; Mata, P.; et al. "Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)". The Lancet 398 10312 (2021): 1713-1725. http://www.scopus.com/inward/record.url?eid=2-s2.0-85115425381&partnerID=MN8TOARS.
    10.1016/S0140-6736(21)01122-3
  5. Alves, A.C.; Azevedo, S.; Benito-Vicente, A.; Graça, R.; Galicia-Garcia, U.; Barros, P.; Jordan, P.; Martin, C.; Bourbon, M.. "LDLR variants functional characterization: Contribution to variant classification". Atherosclerosis 329 (2021): 14-21. http://www.scopus.com/inward/record.url?eid=2-s2.0-85108255315&partnerID=MN8TOARS.
    10.1016/j.atherosclerosis.2021.06.001
  6. Graça, R.; Fernandes, R.; Alves, A.C.; Menezes, J.; Romão, L.; Bourbon, M.. "Characterization of two variants at met 1 of the human ldlr gene encoding the same amino acid but causing different functional phenotypes". Biomedicines 9 9 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85115229933&partnerID=MN8TOARS.
    10.3390/biomedicines9091219
  7. Ana Catarina Alves. "Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.". Arteriosclerosis, thrombosis, and vascular biology (2020): https://doi.org/10.1161/ATVBAHA.120.313722.
    10.1161/atvbaha.120.313722
  8. Ana Catarina Alves. "Metabolic Dysfunction and Asthma: Current Perspectives.". Journal of asthma and allergy (2020): https://europepmc.org/articles/PMC7394599.
    10.2147/jaa.s208823
  9. Leitão, Jorge; Carvalhana, Sofia; Cochicho, Joana; Silva, Ana Paula; Velasco, Francisco; Medeiros, Isabel; Alves, Ana Catarina dos Santos; et al. "Prevalence and risk factors of fatty liver in Portuguese adults". European Journal of Clinical Investigation (2020): http://dx.doi.org/10.1111/eci.13235.
    10.1111/eci.13235
  10. Mariano, Cibelle; Alves, Ana Catarina; Medeiros, Ana Margarida; Chora, Joana Rita; Antunes, Marília; Futema, Marta; Humphries, Steve E.; Bourbon, Mafalda. "The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes". Clinical Genetics 97 3 (2020): 457-466. http://dx.doi.org/10.1111/cge.13697.
    10.1111/cge.13697
  11. Machado, M.V.; Policarpo, S.; Coutinho, J.; Carvalhana, S.; Leitão, J.; Carvalho, A.; Silva, A.P.; et al. "What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?". Obesity Surgery 30 2 (2020): 560-568. http://www.scopus.com/inward/record.url?eid=2-s2.0-85074606382&partnerID=MN8TOARS.
    10.1007/s11695-019-04213-8
  12. Banerjee, P.; Chan, K.-C.; Tarabocchia, M.; Benito-Vicente, A.; Alves, A.C.; Uribe, K.B.; Bourbon, M.; et al. "Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity". Arteriosclerosis, thrombosis, and vascular biology 39 11 (2019): 2248-2260. http://www.scopus.com/inward/record.url?eid=2-s2.0-85074119007&partnerID=MN8TOARS.
    10.1161/ATVBAHA.119.313051
  13. Alves, A.C.; Chora, J.R.; Bourbon, M.. "Genomics of familial hypercholesterolaemia". Current Opinion in Lipidology 30 2 (2019): 148-150. http://www.scopus.com/inward/record.url?eid=2-s2.0-85062631150&partnerID=MN8TOARS.
    10.1097/MOL.0000000000000584
  14. Leitão, J.; Carvalhana, S.; Silva, A.P.; Velasco, F.; Medeiros, I.; Alves, A.C.; Bourbon, M.; et al. "No evidence for lower levels of serum vitamin d in the presence of hepatic steatosis. A study on the portuguese general population". International Journal of Medical Sciences 15 14 (2018): 1778-1786. http://www.scopus.com/inward/record.url?eid=2-s2.0-85058812849&partnerID=MN8TOARS.
    10.7150/ijms.26586
  15. Vallejo-Vaz, A.J.; Marco, M.D.; Stevens, C.A.T.; Akram, A.; Freiberger, T.; Hovingh, G.K.; Kastelein, J.J.P.; et al. "Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)". Atherosclerosis 277 (2018): 234-255. http://www.scopus.com/inward/record.url?eid=2-s2.0-85053666909&partnerID=MN8TOARS.
    10.1016/j.atherosclerosis.2018.08.051
  16. Alves, A.C.; Benito-Vicente, A.; Medeiros, A.M.; Reeves, K.; Martin, C.; Bourbon, M.. "Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia". Atherosclerosis 277 (2018): 448-456. http://www.scopus.com/inward/record.url?eid=2-s2.0-85052284040&partnerID=MN8TOARS.
    10.1016/j.atherosclerosis.2018.06.819
  17. Chora JR; Medeiros AM; Alves AC; Bourbon M. "Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.". Genetics in medicine : official journal of the American College of Medical Genetics (2017): http://europepmc.org/abstract/med/29261184.
    10.1038/gim.2017.151
  18. Bourbon, M.; Alves, A.C.; Alonso, R.; Mata, N.; Aguiar, P.; Padró, T.; Mata, P.. "Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry". Atherosclerosis 262 (2017): 8-13. http://www.scopus.com/inward/record.url?eid=2-s2.0-85018946686&partnerID=MN8TOARS.
    10.1016/j.atherosclerosis.2017.04.002
  19. Santos, R.D.; Bourbon, M.; Alonso, R.; Cuevas, A.; Vasques-Cardenas, N.A.; Pereira, A.C.; Merchan, A.; et al. "Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries". Journal of Clinical Lipidology 11 1 (2017): 160-166. http://www.scopus.com/inward/record.url?eid=2-s2.0-85008240149&partnerID=MN8TOARS.
    10.1016/j.jacl.2016.11.004
  20. Chora, J.R.; Alves, A.C.; Medeiros, A.M.; Mariano, C.; Lobarinhas, G.; Guerra, A.; Mansilha, H.; Cortez-Pinto, H.; Bourbon, M.. "Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?". Journal of Clinical Lipidology 11 2 (2017): 477-484.e2. http://www.scopus.com/inward/record.url?eid=2-s2.0-85019089332&partnerID=MN8TOARS.
    10.1016/j.jacl.2016.11.002
  21. Bourbon, M.; Alves, A.C.; Sijbrands, E.J.. "Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia". Current Opinion in Lipidology 28 2 (2017): 120-129. http://www.scopus.com/inward/record.url?eid=2-s2.0-85011857392&partnerID=MN8TOARS.
    10.1097/MOL.0000000000000404
  22. Carvalhana, S.C.; Leitão, J.; Alves, A.C.; Bourbon, M.; Cortez-Pinto, H.. "Hepatitis B and C prevalence in Portugal: Disparity between the general population and high-risk groups". European Journal of Gastroenterology and Hepatology 28 6 (2016): 640-644. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957837615&partnerID=MN8TOARS.
    10.1097/MEG.0000000000000608
  23. Medeiros, A.M.; Alves, A.C.; Bourbon, M.. "Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: Considerations for genetic diagnosis improvement". Genetics in Medicine 18 4 (2016): 316-324. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962489955&partnerID=MN8TOARS.
    10.1038/gim.2015.71
  24. Fernández-Higuero, J.A.; Etxebarria, A.; Benito-Vicente, A.; Alves, A.C.; Arrondo, J.L.R.; Ostolaza, H.; Bourbon, M.; Martin, C.. "Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity". Scientific Reports 5 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84949524038&partnerID=MN8TOARS.
    10.1038/srep18184
  25. Alves, A.C.; Etxebarria, A.; Medeiros, A.M.; Benito-Vicente, A.; Thedrez, A.; Passard, M.; Croyal, M.; et al. "Characterization of the First PCSK9 Gain of Function Homozygote". Journal of the American College of Cardiology 66 19 (2015): 2152-2154. http://www.scopus.com/inward/record.url?eid=2-s2.0-84958093453&partnerID=MN8TOARS.
    10.1016/j.jacc.2015.08.871
  26. Benito-Vicente, A.; Alves, A. C.; Etxebarria, A.; Medeiros, A. M.; Martin, C.; Bourbon, M.. "The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia". Genet Med (2015):
    10.1038/gim.2015.14
  27. Etxebarria, A.; Benito-Vicente, A.; Alves, A. C.; Ostolaza, H.; Bourbon, M.; Martin, C.. "Advantages and Versatility of Fluorescence-Based Methodology to Characterize the Functionality of LDLR and Class Mutation Assignment". PLoS One 9 11 (2014): e112677-e112677.
    10.1371/journal.pone.0112677
  28. Medeiros, A. M.; Alves, A. C.; Aguiar, P.; Bourbon, M.; Pediatric Investigators of the Portuguese Familial Hypercholesterolemia Study. "Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia". J Lipid Res 55 5 (2014): 947-55.
    10.1194/jlr.P043182
  29. Alves, A. C.; Etxebarria, A.; Soutar, A. K.; Martin, C.; Bourbon, M.. "Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia". Hum Mol Genet 23 7 (2014): 1817-28.
    10.1093/hmg/ddt573
  30. Rocha, T.; Rocha, E.; Alves, A. C.; Medeiros, A. M.; Francisco, V.; Silva, S.; Mendes Gaspar, I.; Rato, Q.; Bourbon, M.. "Cardiovascular risk profile of high school students: a cross-sectional study". Rev Port Cardiol 33 9 (2014): 525-34.
    10.1016/j.repc.2014.01.024
  31. Carvalhana, Sofia; Leitão, Jorge; Alves, Ana C.; Bourbon, Mafalda; Cortez-Pinto, Helena. "How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound". Liver International n/a (2013): n/a-n/a.
    Published • 10.1111/liv.12305
  32. Espinheira, M.o C; Vasconcelos, C.; Medeiros, A. M.; Alves, A. C.; Bourbon, M.; Guerra, A.. "Hypercholesterolemia--a disease with expression from childhood". Rev Port Cardiol 32 5 (2013): 379-86.
    10.1016/j.repc.2012.09.008
  33. Silva, S.; Alves, A. C.; Patel, D.; Malhó, R.; Soutar, A. K.; Bourbon, M.. "In vitro functional characterization of missense mutations in the LDLR gene". Atherosclerosis 225 1 (2012): 128-34.
    10.1016/j.atherosclerosis.2012.08.017
  34. Alves, A.C.; Medeiros, A.M.; Francisco, V.; Gaspar, I.M.; Rato, Q.; Bourbon, M.. "Molecular diagnosis of familial hypercholesterolemia: An important tool for cardiovascular risk stratification". Revista Portuguesa de Cardiologia 29 6 (2010): 907-921. http://www.scopus.com/inward/record.url?eid=2-s2.0-77957736659&partnerID=MN8TOARS.
    Open access
  35. Medeiros, A. M.; Alves, A. C.; Francisco, V.; Bourbon, M.; investigators of the Portuguese FH Study. "Update of the Portuguese Familial Hypercholesterolaemia Study". Atherosclerosis 212 2 (2010): 553-8.
    10.1016/j.atherosclerosis.2010.07.012
  36. Alves, A. C.; Medeiros, A. M.; Francisco, V.; Gaspar, I. M.; Rato, Q.; Bourbon, M.. "Molecular diagnosis of familial hypercholesterolemia: an important tool for cardiovascular risk stratification". Rev Port Cardiol 29 6 (2010): 907-21.
  37. Bourbon, M.; Duarte, M. A.; Alves, A. C.; Medeiros, A. M.; Marques, L.; Soutar, A. K.. "Genetic diagnosis of familial hypercholesterolaemia: the importance of functional analysis of potential splice-site mutations". J Med Genet 46 5 (2009): 352-7.
    10.1136/jmg.2007.057000
  38. Bourbon, M.; Alves, A. C.; Medeiros, A. M.; Silva, S.; Soutar, A. K.; Investigators of Portuguese FH Study. "Familial hypercholesterolaemia in Portugal". Atherosclerosis 196 2 (2008): 633-42.
    10.1016/j.atherosclerosis.2007.07.019
Thesis / Dissertation
  1. dos Santos Alves, Ana Catarina. "Base genética da hipercolesterolemia familiar". PhD, 2014. http://hdl.handle.net/10400.18/2766.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2021/02/25 Functional characterization of variants associated with Familial Hypercholesterolemia Insa Convida
Instituto Nacional de Saúde Doutor Ricardo Jorge (Lisboa, Portugal)
2020/02/04 estudo e_COR: Prevalência dos fatores de risco cardiovasculares na população portuguesa Seminários de Investigação Ricardo Jorge
Instituto Nacional de Saúde Doutor Ricardo Jorge (Lisboa, Portugal)
2019/04/06 Molecular diagnosis of monogenic dyslipidaemia. 11ª Reunião Científica SPML
sociedade portuguesa de medicina laboratorial (Coimbra, Portugal)
2018/05/05 Familial Hypercholesterolaemia in Portugal 5th Meeting of the Iberoamerican FH network
Iberoamerican FH network (Lisboa, Portugal)
2015/11/11 Estudos de prevalência de determinantes de saúde: e_COR 7º Encontro Nacional dos Médicos de Saúde Pública
Sociedade Portuguesa dos Médicos de Saúde Pública (Braga, Portugal)
2014/06/02 “Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolemia”. 83º European Atherosclerosis Congress
European Atherosclerosis Society (Madrid, Spain)
2014/04/12 “Prevalência de fatores de risco cardiovascular na população Portuguesa: e_COR” XI Jornadas Médico Desportivas
(Paços de Ferreira)
2012 Functional Studies of LDLR Mutations XXXIII Congresso Português de Cardiologia
Sociedade Portuguesa de Cardiologia (Vilamoura, Portugal)
2011/12/06 Genetic Disorders of Lipoprotein Metabolism seminar to the students of Nutrition from Instituto Piaget
Instituto Piaget (Almada, Portugal)
2009/04/21 "Hipercolesterolemia Familiar: uma oportunidade para a medicina preventiva" XXX Congresso Português de Cardiologia
Sociedade Portuguesa de Cardiologia (Vilamoura, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2020 - Current Molecular Study of Familial Dyslipidaemias by Next Generation Sequencing
Co-supervisor
 Bioquímica (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
2020 - Current Health inequalities in cerebro and cardiovascular health – an analysis of the e_COR study
Co-supervisor
 Bioestatística (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal
2018 - 2020/06 Prevalence of Thrombogenic Risk Factors in the Portuguese population and Identification of High-risk Individuals in Portugal
Supervisor of Micaela Santos
 Biofarmácia e Farmacocinética Avançada (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2018/01/04 - 2018/05/05 5th Iberoamerican FH Network meeting (2018/05/04 - 2018/05/05)
Meeting (Member of the Organising Committee)
 Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
2016/10/01 - 2017/03/22 Course on “Identification and treatment of patients with Familial Hypercholesterolameia” (2017/03/22 - 2017/03/22)
Workshop (Member of the Organising Committee)
 Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2019/11/14 Classification Methods applied to Familial Hypercholesterolemia Diagnosis in Pediatric Age João David Ferreira de Castro e Albuquerque (Master)
Universidade de Lisboa Faculdade de Ciências, Portugal

Association member

Society Organization name Role
2009 - Current Member of the European Atherosclerosis Society membro
2006 - Current Member of the Portuguese Society Cardiology sócia

Conference scientific committee

Conference name Conference host
2016 - 2016 European Atherosclerosis Congress Insbruck

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2016/01/22 - 2016/01/22 Aula no Curso de Pós-Graduação em Patologia Molecular - “Diagnóstico Molecular de Dislipidemias Familiar” Pós-Graduação em Patologia Molecular (Pós-Graduação) Escola Superior de Saúde Egas Moniz, Portugal

Journal scientific committee

Journal title (ISSN) Publisher
2019 - Current Clinical Genetics (1399-0004) Wiley (Blackwell Publishing)
2018 - Current Atherosclerosis (2590-1354) Elsevier
2018 - Current Journal of Clinical Lipidology (1933-2874) Elsevier
2018 - Current Gene (0378-1119) Elsevier
Distinctions

Award

2019 BIAL AWARD in CLINICAL MEDICINE
Fundação Bial, Portugal
2014 1ST PRIZE YOUNG INVESTIGATOR AWARD
European Atherosclerosis Society, Sweden
2012 Prémio Jovem Investigador - investigação básica
Sociedade Portuguesa de Cardiologia, Portugal
2009 Pfizer Award for Clinical Research
Pfizer Laboratories and Society of Medical Sciences of Lisbon., Portugal

Other distinction

2005 Best Communication
2004 Institute Hipócrates